drugset / Trial / NCT03163693
The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients undergoing off-pump coronary artery bypass Grafting.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
Indications
No indication recorded.